Most patients see net blood pressure reduction over time, but the trajectory is less predictable
Eat better Eating food (in general) naturally increases GLP-1
It is currently undergoing clinical trials
This large study, which included more than 17,500 patients, showed that adding semaglutide to their standard care significantly reduced the risk of heart attack, stroke, or death by cardiovascular disease
Semaglutide may have slightly higher rates of these effects in clinical trials, likely reflecting its greater potency
One patient achieved 33 percent total body weight loss over 115 weeks, but 91.2 percent of that weight loss came from fat, with only 8.7 percent from lean tissue